Clinical trial
A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in…
NCT00236379 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00236379 |
|---|---|
| Title | A Study of the Effects of Risperidone and Olanzapine on Blood Glucose (Sugar) in Patients With Schizophrenia or Schizoaffective Disorder |
| Official title | A Six-month, Double-blind, Randomized, International, Multicenter Trial to Evaluate the Glucoregulatory Effects of Risperidone and Olanzapine in Subjects With Schizophrenia or Schizoaffective Disorder |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Schizophrenia, Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | Olanzapine, Risperidone |
| Enrollment | 59 |
| Completion | Aug 1, 2003 |
| First posted | Oct 12, 2005 |
| Last update posted | May 17, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: